The company said it will use the net proceeds to redeem the outstanding $500 million aggregate principal amount of senior notes maturing in January 2018.
The ratings agency also assigned a Negative Rating Watch to the firm's notes offering, noting it will resolve this notation as more details of the offering become available.
The firm plans to use the funds to repay outstanding debts and for general corporate purposes.
The firm has not disclosed the amount it is seeking, but said it plans to use the funds to repay outstanding debts and for general corporate purposes.
The company said it will use most of the proceeds to redeem the outstanding $900 million principal amount of its 1.30 percent senior notes due 2017.
Fitch has given the two-year senior notes offering a BBB rating with a Stable outlook.
The 10-year notes were rated BBB by Fitch, which also declared the ratings outlook Stable.
The firm sold three series of senior notes and will use proceeds to repay other outstanding debt.
The firm will use the proceeds along with cash on hand to redeem notes that mature in August.
The Salt Lake City-based company said it would use the $18.4 million in expected gross aggregate proceeds for product pipeline development and customer growth.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.